Drug Trial Radar · NCT03922373
A Study of Benzonatate Soft Capsule in Chinese Healthy Subjects
Last checked: Nov 20, 2026Latest source record: Apr 19, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
40
Planned (sponsor's estimate)
Start
Sep 10, 2018
Primary completion
Feb 27, 2019
Study completion Apr 30, 2019
Sponsor
- Lead sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 19, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Objective to study the pharmacokinetic, safety and efficacy of Single-dose and multiple-dose of benzonatate in Chinese healthy male and female subjects.
Conditions
- Cough
Interventions
Group A: Benzonatate 100mgDrug
Subjects in group A will be given benzonatate 100mg once after a 10-hour fast in the first day of the trail
Group B: Benzonatate 200mgDrug
Subjects in group B will be given benzonatate 200mg once after a 10-hour fast in the first day of the trail, and they will be given benzonatate 200mg thrice in the second and third day of the trail, in the fourth day, they will be given benzonatate 200mg once after a 10-hour fast.
Group C: Benzonatate 400mgDrug
Subjects in group C will be given benzonatate 400mg once after a 10-hour fast in the first day of the trail
Primary outcomes
What the sponsor says the trial is designed to measure.
- TmaxTime frame: day 1 and day 4
- CmaxTime frame: day 1 and day 4
- t1/2Time frame: day 1 and day 4
- AUC0-tTime frame: day 1 and day 4
- AUC0-∞Time frame: day 1 and day 4
- CL/FTime frame: day 1 and day 4
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cspc Nbp Pharmaceutical.Co.Ltd
Shijiazhuang, Hebei, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.